01 · Clinical foundation
Define the medical logic
Clarify the clinical need, intended purpose, medical requirements, intended users and defensible claims.
We like healthcare.
We love to innovate it.
Healthcare innovation. Made in Europe.
From technical promise to clinical reality
Quint Healthcare helps medical technology, diagnostic and digital health organisations turn promising ideas and products into clinically credible, evidence-based and implementable solutions.
The work connects medicine, product strategy, clinical evidence, European regulation and adoption. It is led by a physician and scientist who can translate between clinicians, engineers, regulatory teams, management, investors and public partners.
Innovation works when the decisions connect
A technically sound product can still fail if the clinical need is unclear, the intended purpose is unstable, the evidence does not support the claim or the technology adds friction to an already constrained workflow.
Quint Healthcare helps teams address these dependencies early. The objective is to make the medical logic explicit, identify the decisions that matter and build a practical path from concept to clinical use.
The work is organised around four connected decision areas:
02 · Evidence and validation
Demonstrate what matters
Connect claims to evidence requirements, identify gaps and design proportionate clinical investigations or validation studies.
03 · European adoption
Prepare the path into practice
Align regulation, reimbursement and market-entry questions with procurement and clinical-workflow requirements.
04 · Medical leadership and delivery
Keep the decisions connected
Provide senior medical ownership for product, programme and investment decisions, and build credible European funding strategies and consortia.
Support across the medical technology journey
01 · European regulation
EU regulatory affairs and clinical evaluation
Build a coherent clinical-regulatory position under the MDR or IVDR, identify evidence gaps and prepare clinical evaluation and lifecycle evidence that can withstand scrutiny.
02 · Evidence
Clinical evidence and medical device studies
Define what must be demonstrated, for whom and with which endpoints, then design the smallest credible study or evidence programme that can answer the relevant questions.
03 · Adoption
European market access and clinical adoption
Translate approval into a realistic path towards procurement, reimbursement, reference sites and routine use in Germany and other European markets.
04 · Leadership
Medical product strategy and fractional medical leadership
Bring medical ownership into product decisions, claims, risk, due diligence and multidisciplinary programmes without necessarily building a full internal medical function.
05 · European programmes
European funding and consortium development
Connect clinical value, technical development, validation and exploitation in credible European proposals and multi-partner projects.
06 · Specialist focus
Digital pathology and intraoperative imaging
Apply specialist clinical and translational experience to workflow-intensive technologies in pathology, microscopy, medical optics and image-guided intervention.
Why an integrated approach matters now
Europe remains a major medical-technology market, but companies must operate across fragmented health systems while clinical, regulatory, data and AI requirements increasingly converge.
MDR and IVDR implementation continues to evolve. For relevant AI-enabled products, the EU AI Act introduces an additional regulatory layer, while the European Health Data Space is changing expectations around access to and use of health data. These developments increase the cost of treating medical, technical and regulatory questions separately.
At the same time, European health systems face substantial workforce constraints. New technology must therefore demonstrate not only that it works, but that it improves care without creating avoidable work or implementation risk.
This makes clinical reasoning a business issue. Intended purpose, evidence, workflow, regulation and adoption need to be treated as connected decisions rather than consecutive documents.
Selected public experience
Our projects. Our clients.
Quint Healthcare has contributed to medical technology, diagnostics, innovation and funding work with startups, established companies, research organisations and European programmes.
Discretion is integral to this work. Many engagements involve sensitive clinical questions, unpublished evidence, emerging product strategies or confidential business decisions. They are handled with the professional care, integrity and respect for confidentiality expected in both medical practice and trusted business relationships.
The selection below is therefore limited to publicly disclosed work. It illustrates the range of settings in which Quint Healthcare contributes: from early medical concepts and translational projects to established manufacturers and European programmes.
Expert appointment
European Commission
Expert evaluation for the European Commission Research Executive Agency.
Mentoring
Science4Life
Startup mentoring through the Science4Life business-plan competition.
Medical technology
CeramOptec
Work related to optical fibres for medical-laser applications.
Clinical innovation
Paracelsus Medical University
An innovative extracorporeal life-support project.
Diagnostic imaging
Siemens Healthineers
Intelligent assistance in diagnostic imaging.
Diagnostics
SYNLAB
Gastrointestinal cancer screening work.
Research and development
Fraunhofer IIS
A non-invasive, real-time mobile diagnostic system.
Mentoring
EIT Health
Mentoring within the EIT Health network.
Surgical technology
Robota
An automated system for sterilisation and surgical-instrument management.
We love humans. Let us talk.
Let us start with the difficult decision you are facing
A useful first conversation does not require a polished brief. Bring the question, the deadline and the evidence currently available. Together, we can determine whether Quint Healthcare is the right partner and what a proportionate first scope would look like.
Our international approach
Based in Europe. Working internationally.
European regulatory and market-access work is focused on the European Union and Germany. Medical strategy, clinical concept development, evidence planning, study design, due diligence and specialist work in pathology and imaging can support organisations internationally.
